医療安全と世界の健康
オープンアクセス

概要

産科婦人科2020：メトホルミンの使用が卵巣癌のリスクと予後に及ぼす影響：最新の系統的レビューとメタアナリシス-ミンジェン・ルー、第二臨床医学大学

呂 ミンジェン

Emerging evidences suggest that metformin has a potential antitumor effect both in vitro and in vivo. Increasing epidemiological studies indicate that diabetic patients receiving metformin therapy have lower incidences of cancer and have better survival rates. However, there are limited and inconsistent studies available about the effect of metformin therapy on ovarian cancer (OC). Thus, we conducted this meta-analysis to study the effect of metformin therapy on OC. Meanwhile, we systematically reviewed relevant studies to provide a framework for future research